Clinical trial
Safety and Efficacy of a Sublingual Specific Immunotherapy With an Extract of a…
NCT00264459 · Allergopharma GmbH & Co. KG, Industry · Completed
Key facts
| NCT number | NCT00264459 |
|---|---|
| Title | Safety and Efficacy of a Sublingual Specific Immunotherapy With an Extract of a Six Grass Pollen Mixture |
| Official title | A Multicentre, Placebo-controlled, Double-blind Study to Evaluate Efficacy and Safety of a Perennial Sublingual Specific Immunotherapy With a Liquid Formulation of an Extract of a Six Grass Pollen-mixture in Patients With Clinically Relevant Grass Pollen Sensitivity. |
| Lead sponsor | Allergopharma GmbH & Co. KG, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Grass Pollen Allergy |
| Intervention type | Biological, Other |
| Interventions | Grass pollen formulation, Comparator |
| Enrollment | 160 |
| Start date | Feb 1, 2003 |
| Primary completion | Aug 1, 2008 |
| Completion | Sep 1, 2011 |
| First posted | Dec 13, 2005 |
| Last update posted | Jan 24, 2014 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: